Methods of Formal Consensus in Classification/Diagnostic Criteria and Guideline Development

被引:315
作者
Nair, Raj [2 ]
Aggarwal, Rohit [3 ]
Khanna, Dinesh [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, 1000 Vet Ave,Rm 32-59,Rehabil Bldg, Los Angeles, CA 90095 USA
[2] Washington Hosp Ctr, Dept Med, Washington, DC 20010 USA
[3] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
guideline criteria; formal consensus methods; Delphi method; nominal group technique; RAND/UCLA Appropriateness Method; National Institutes of Health consensus development; conference; GRADE; diagnostic criteria; SYSTEMIC-LUPUS-ERYTHEMATOSUS; QUALITY-OF-CARE; RHEUMATOID-ARTHRITIS; CLINICAL REMISSION; SELECT CATEGORIES; DISEASE-ACTIVITY; PROSPECTIVE VALIDATION; APPROPRIATENESS METHOD; DEVELOPMENT PROGRAM; NOMINAL GROUP;
D O I
10.1016/j.semarthrit.2010.12.001
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Guidelines or diagnostic criteria in clinical practice assist physicians in their clinical decision-making and improve health outcomes for patients. Diagnostic and classification criteria should be based on evidence from rigorously conducted controlled studies. Formal group consensus methods have been developed to organize subjective judgments and to synthesize them with the available evidence. This review discusses 4 types of formal consensus methods used in the health field and their applications in rheumatology: the Delphi method, Nominal Group Technique, RAND/UCLA Appropriateness Method, and National Institutes of Health consensus development conference. (C) 2011 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 41:95-105
引用
收藏
页码:95 / 105
页数:11
相关论文
共 69 条
[1]
Agency for Healthcare Policy and Research, 1995, AHCPR CLIN PRACT GUI
[2]
[Anonymous], 2003, NIH Consens State Sci Statements, V20, P1
[3]
[Anonymous], 1994, NIH Consens Statement, V12, P1
[4]
[Anonymous], 1990, Consens Statement, V8, P1
[5]
[Anonymous], 2002, The Delphi Method
[6]
The primary and secondary prevention of coronary artery disease [J].
Becker, Richard C. ;
Meade, Thomas W. ;
Berger, Peter B. ;
Ezekowitz, Michael ;
O'Connor, Christopher M. ;
Vorchheimer, David A. ;
Guyatt, Gordon H. ;
Mark, Daniel B. ;
Harrington, Robert A. .
CHEST, 2008, 133 (06) :776S-814S
[7]
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics [J].
Bertsias, G. ;
Ioannidis, J. P. A. ;
Boletis, J. ;
Bombardieri, S. ;
Cervera, R. ;
Dostal, C. ;
Font, J. ;
Gilboe, I. M. ;
Houssiau, F. ;
Huizinga, T. ;
Isenberg, D. ;
Kallenberg, C. G. M. ;
Khamashta, M. ;
Piette, J. C. ;
Schneider, M. ;
Smolen, J. ;
Sturfelt, G. ;
Tincani, A. ;
van Vollenhoven, R. ;
Gordon, C. ;
Boumpas, D. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) :195-205
[8]
Black N, 1999, J Health Serv Res Policy, V4, P236
[9]
Chassin M, 1989, Appropriate Investigation and Treatment in Clinical Practice, P21
[10]
HOW CORONARY ANGIOGRAPHY IS USED - CLINICAL DETERMINANTS OF APPROPRIATENESS [J].
CHASSIN, MR ;
KOSECOFF, J ;
SOLOMON, DH ;
BROOK, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (18) :2543-2547